Production of bioactive, SUMO-modified, and native-like TNF-α of the rhesus monkey, Macaca mulatta, in Escherichia coli (Q39420709)

11 September 2017

title

Production of bioactive, SUMO-modified, and native-like TNF-α of the rhesus monkey, Macaca mulatta, in Escherichia coli (English)

1 reference

11 September 2017

0 references

0 references

Macaca mulatta

1 reference

Dianlong Jia

1

1 reference

11 September 2017

Hao Yang

2

1 reference

11 September 2017

Lin Wan

3

1 reference

11 September 2017

Jingqiu Cheng

4

1 reference

11 September 2017

Xiaofeng Lu

5

1 reference

11 September 2017

language of work or name

English

0 references

publication date

30 December 2011

1 reference

Applied Microbiology and Biotechnology

11 September 2017

published in

1 reference

11 September 2017

volume

93

1 reference

11 September 2017

issue

6

1 reference

11 September 2017

page(s)

2345-2355

1 reference

A long-acting tumor necrosis factor alpha-binding protein demonstrates activity in both in vitro and in vivo models of endometriosis

11 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00253-011-3794-1

Tumor necrosis factor-alpha in the pathogenesis and treatment of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-011-3794-1

The dual role of tumor necrosis factor (TNF) in cancer biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-011-3794-1

SUMO fusion technology for difficult-to-express proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-011-3794-1

An endotoxin-induced serum factor that causes necrosis of tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-011-3794-1

TNF-alpha as a therapeutic target in inflammatory diseases, ischemia-reperfusion injury and trauma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-011-3794-1

Attachment of histidine tags to recombinant tumor necrosis factor-alpha drastically changes its properties.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-011-3794-1

Improving TNF as a cancer therapeutic: tailor-made TNF fusion proteins with conserved antitumor activity and reduced systemic side effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-011-3794-1

Recombinant production of bioactive human TNF-alpha by SUMO-fusion system--high yields from shake-flask culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-011-3794-1

TNF: a moonlighting protein at the interface between cancer and infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-011-3794-1

Single-chain TNF, a TNF derivative with enhanced stability and antitumoral activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-011-3794-1

The immunocytokine scFv23/TNF targeting HER-2/neu induces synergistic cytotoxic effects with 5-fluorouracil in TNF-resistant pancreatic cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-011-3794-1

Targeted lipid-coated nanoparticles: delivery of tumor necrosis factor-functionalized particles to tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-011-3794-1

Human tumour necrosis factor: precursor structure, expression and homology to lymphotoxin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-011-3794-1

Amphipathic peptide-based fusion peptides and immunoconjugates for the targeted ablation of prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-011-3794-1

A practical, evidence-based guide to the use of adalimumab in Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-011-3794-1

Targeting TNF for Treatment of Cancer and Autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-011-3794-1

Molecular cloning and functional characterization of bottlenose dolphin (Tursiops truncatus) tumor necrosis factor alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-011-3794-1

Tumour necrosis factor-alpha as a tumour promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-011-3794-1

Effectiveness of regional chemotherapy with TNF-alpha/melphalan in advanced soft tissue sarcoma of the extremities.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-011-3794-1

Anti-TNF biologic agents: still the therapy of choice for rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-011-3794-1

Tumour necrosis factor-alpha in Barrett's oesophagus: a potential novel mechanism of action.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-011-3794-1

TNF-alpha in cancer treatment: molecular insights, antitumor effects, and clinical utility

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-011-3794-1

Preclinical models of arthritic disease in non-human primates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-011-3794-1

Cloning, sequencing, and homology analysis of nonhuman primate Fas/Fas-ligand and co-stimulatory molecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-011-3794-1

Tumour necrosis factor antagonists: structure, function, and tuberculosis risks

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-011-3794-1

Integrin-targeted imaging and therapy with RGD4C-TNF fusion protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-011-3794-1

Molecular cloning and characterization of tumor necrosis factor alpha (TNF-alpha) from the Australian common brushtail possum, Trichosurus vulpecula

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-011-3794-1

Recombinant CPE fused to tumor necrosis factor targets human ovarian cancer cells expressing the claudin-3 and claudin-4 receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-011-3794-1

10.1007/S00253-011-3794-1

21 January 2018

Identifiers

DOI

1 reference

11 September 2017

1 reference